Xiamen Reconciled Depreciation vs Ebitda Analysis

688278 Stock

79.77 0.51 0.64%

Xiamen Amoytop financial indicator trend analysis is more than just analyzing Xiamen Amoytop Biotech current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Xiamen Amoytop Biotech is a good investment. Please check the relationship between Xiamen Amoytop Reconciled Depreciation and its Ebitda accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Xiamen Amoytop Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Reconciled Depreciation vs Ebitda

Reconciled Depreciation vs Ebitda Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Xiamen Amoytop Biotech Reconciled Depreciation account and Ebitda. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Xiamen Amoytop's Reconciled Depreciation and Ebitda is 0.91. Overlapping area represents the amount of variation of Reconciled Depreciation that can explain the historical movement of Ebitda in the same time period over historical financial statements of Xiamen Amoytop Biotech, assuming nothing else is changed. The correlation between historical values of Xiamen Amoytop's Reconciled Depreciation and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Reconciled Depreciation of Xiamen Amoytop Biotech are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Reconciled Depreciation i.e., Xiamen Amoytop's Reconciled Depreciation and Ebitda go up and down completely randomly.

Correlation Coefficient

0.91

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Reconciled Depreciation

Ebitda

Most indicators from Xiamen Amoytop's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Xiamen Amoytop Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Xiamen Amoytop Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Tax Provision is expected to grow to about 102.9 M, whereas Selling General Administrative is forecasted to decline to about 531.3 M.

	2022	2023	2024	2025 (projected)
Gross Profit	1.4B	2.0B	2.3B	2.4B
Total Revenue	1.5B	2.1B	2.4B	2.5B

Gross Profit Total Revenue

Xiamen Amoytop fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Net Receivables	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Non Current Liabilities Other	Intangible Assets	Common Stock	Property Plant Equipment	Common Stock Shares Outstanding	Net Invested Capital
Total Assets		-0.5	0.97	1.0	0.69	0.96	1.0	0.64	0.86	0.99	0.98	0.82	0.96	0.71	0.99	-0.14	0.86	0.6	-0.9	1.0	0.86	0.87	0.9	0.79	0.92	0.89
Other Current Liab	-0.5		-0.64	-0.49	0.05	-0.39	-0.54	-0.56	-0.34	-0.59	-0.45	-0.45	-0.59	0.02	-0.41	0.84	-0.49	-0.45	0.21	-0.44	-0.33	-0.54	-0.31	-0.23	-0.33	-0.42
Total Current Liabilities	0.97	-0.64		0.96	0.57	0.88	0.98	0.6	0.82	0.99	0.96	0.79	0.98	0.58	0.94	-0.29	0.85	0.61	-0.78	0.95	0.79	0.83	0.81	0.69	0.84	0.83
Total Stockholder Equity	1.0	-0.49	0.96		0.7	0.97	0.99	0.64	0.86	0.99	0.98	0.82	0.95	0.71	0.99	-0.13	0.85	0.6	-0.91	1.0	0.87	0.87	0.91	0.8	0.93	0.9
Other Liab	0.69	0.05	0.57	0.7		0.71	0.66	0.54	0.76	0.63	0.64	0.36	0.58	0.98	0.77	0.5	0.72	0.04	-0.86	0.73	0.88	0.59	0.74	0.72	0.74	0.73
Net Tangible Assets	0.96	-0.39	0.88	0.97	0.71		0.94	0.7	0.86	0.95	0.92	0.87	0.85	0.75	0.96	-0.05	0.82	0.66	-0.95	0.97	0.86	0.88	0.92	0.87	0.94	0.89
Retained Earnings	1.0	-0.54	0.98	0.99	0.66	0.94		0.62	0.86	1.0	0.98	0.81	0.97	0.67	0.98	-0.18	0.87	0.6	-0.87	0.99	0.85	0.87	0.87	0.77	0.9	0.89
Accounts Payable	0.64	-0.56	0.6	0.64	0.54	0.7	0.62		0.69	0.66	0.5	0.59	0.49	0.63	0.62	-0.19	0.73	0.42	-0.7	0.62	0.73	0.75	0.62	0.74	0.61	0.71
Cash	0.86	-0.34	0.82	0.86	0.76	0.86	0.86	0.69		0.85	0.85	0.74	0.79	0.75	0.87	0.01	0.98	0.53	-0.86	0.87	0.95	0.92	0.9	0.94	0.88	0.98
Non Current Assets Total	0.99	-0.59	0.99	0.99	0.63	0.95	1.0	0.66	0.85		0.97	0.83	0.96	0.65	0.97	-0.24	0.86	0.63	-0.86	0.98	0.84	0.88	0.87	0.77	0.89	0.88
Non Currrent Assets Other	0.98	-0.45	0.96	0.98	0.64	0.92	0.98	0.5	0.85	0.97		0.81	0.97	0.64	0.97	-0.15	0.83	0.61	-0.85	0.97	0.82	0.85	0.87	0.76	0.9	0.87
Other Assets	0.82	-0.45	0.79	0.82	0.36	0.87	0.81	0.59	0.74	0.83	0.81		0.72	0.43	0.76	-0.32	0.68	0.94	-0.71	0.8	0.61	0.81	0.76	0.76	0.78	0.75
Net Receivables	0.96	-0.59	0.98	0.95	0.58	0.85	0.97	0.49	0.79	0.96	0.97	0.72		0.57	0.94	-0.25	0.82	0.52	-0.76	0.95	0.78	0.79	0.8	0.64	0.84	0.82
Non Current Liabilities Total	0.71	0.02	0.58	0.71	0.98	0.75	0.67	0.63	0.75	0.65	0.64	0.43	0.57		0.78	0.46	0.71	0.11	-0.89	0.74	0.87	0.62	0.74	0.76	0.74	0.72
Inventory	0.99	-0.41	0.94	0.99	0.77	0.96	0.98	0.62	0.87	0.97	0.97	0.76	0.94	0.78		-0.02	0.86	0.51	-0.93	1.0	0.89	0.84	0.9	0.8	0.92	0.89
Other Current Assets	-0.14	0.84	-0.29	-0.13	0.5	-0.05	-0.18	-0.19	0.01	-0.24	-0.15	-0.32	-0.25	0.46	-0.02		-0.12	-0.47	-0.19	-0.06	0.09	-0.28	0.02	0.04	0.0	-0.08
Total Liab	0.86	-0.49	0.85	0.85	0.72	0.82	0.87	0.73	0.98	0.86	0.83	0.68	0.82	0.71	0.86	-0.12		0.47	-0.8	0.85	0.95	0.93	0.86	0.89	0.85	0.97
Deferred Long Term Liab	0.6	-0.45	0.61	0.6	0.04	0.66	0.6	0.42	0.53	0.63	0.61	0.94	0.52	0.11	0.51	-0.47	0.47		-0.44	0.57	0.33	0.64	0.54	0.56	0.56	0.54
Short Long Term Debt	-0.9	0.21	-0.78	-0.91	-0.86	-0.95	-0.87	-0.7	-0.86	-0.86	-0.85	-0.71	-0.76	-0.89	-0.93	-0.19	-0.8	-0.44		-0.92	-0.91	-0.81	-0.9	-0.88	-0.9	-0.88
Total Current Assets	1.0	-0.44	0.95	1.0	0.73	0.97	0.99	0.62	0.87	0.98	0.97	0.8	0.95	0.74	1.0	-0.06	0.85	0.57	-0.92		0.88	0.85	0.91	0.8	0.93	0.89
Non Current Liabilities Other	0.86	-0.33	0.79	0.87	0.88	0.86	0.85	0.73	0.95	0.84	0.82	0.61	0.78	0.87	0.89	0.09	0.95	0.33	-0.91	0.88		0.88	0.89	0.9	0.88	0.95
Intangible Assets	0.87	-0.54	0.83	0.87	0.59	0.88	0.87	0.75	0.92	0.88	0.85	0.81	0.79	0.62	0.84	-0.28	0.93	0.64	-0.81	0.85	0.88		0.9	0.93	0.89	0.96
Common Stock	0.9	-0.31	0.81	0.91	0.74	0.92	0.87	0.62	0.9	0.87	0.87	0.76	0.8	0.74	0.9	0.02	0.86	0.54	-0.9	0.91	0.89	0.9		0.89	1.0	0.93
Property Plant Equipment	0.79	-0.23	0.69	0.8	0.72	0.87	0.77	0.74	0.94	0.77	0.76	0.76	0.64	0.76	0.8	0.04	0.89	0.56	-0.88	0.8	0.9	0.93	0.89		0.87	0.94
Common Stock Shares Outstanding	0.92	-0.33	0.84	0.93	0.74	0.94	0.9	0.61	0.88	0.89	0.9	0.78	0.84	0.74	0.92	0.0	0.85	0.56	-0.9	0.93	0.88	0.89	1.0	0.87		0.92
Net Invested Capital	0.89	-0.42	0.83	0.9	0.73	0.89	0.89	0.71	0.98	0.88	0.87	0.75	0.82	0.72	0.89	-0.08	0.97	0.54	-0.88	0.89	0.95	0.96	0.93	0.94	0.92

Click cells to compare fundamentals

Xiamen Amoytop Account Relationship Matchups

Xiamen Amoytop fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	1.2B	1.4B	1.8B	2.4B	2.7B	2.8B
Other Current Liab	27.9M	32.9M	217.0K	142.7K	128.4K	122.0K
Total Current Liabilities	114.9M	177.2M	267.9M	403.7M	464.2M	487.4M
Total Stockholder Equity	1.0B	1.2B	1.4B	1.9B	2.2B	2.3B
Other Liab	78.5M	75.5M	77.4M	76.3M	87.8M	68.8M
Net Tangible Assets	367.1M	828.1M	1.0B	1.2B	1.4B	1.4B
Retained Earnings	196.6M	357.4M	530.8M	955.0M	1.1B	1.2B
Accounts Payable	7.1M	8.1M	97.3M	40.6M	46.7M	24.1M
Cash	197.2M	285.4M	301.2M	413.0M	474.9M	242.9M
Non Current Assets Total	419.9M	589.8M	812.9M	1.0B	1.2B	1.2B
Non Currrent Assets Other	17.7M	45.8M	26.4M	75.8M	87.2M	91.5M
Other Assets	39.7M	52.0M	120.9M	249.9M	287.4M	301.8M
Net Receivables	162.9M	186.4M	217.1M	437.8M	503.5M	528.7M
Non Current Liabilities Total	77.4M	85.7M	93.1M	76.0M	87.4M	76.2M
Inventory	99.6M	116.5M	129.7M	187.0M	215.1M	225.8M
Other Current Assets	10.8M	8.2M	1.7M	923.8K	1.1M	1.0M
Total Liab	192.3M	262.9M	361.0M	479.7M	551.6M	281.7M
Deferred Long Term Liab	11.3M	23.5M	78.2M	169.1M	194.5M	204.2M
Short Long Term Debt	18.9M	15.8M	4.2M	4.2M	3.7M	3.6M
Total Current Assets	772.8M	834.4M	955.6M	1.3B	1.5B	1.6B
Non Current Liabilities Other	17.5M	19.5M	26.0M	31.2M	35.9M	19.1M
Intangible Assets	249.5M	309.7M	342.1M	352.7M	405.5M	301.6M
Property Plant Equipment	74.1M	96.2M	126.7M	192.9M	221.9M	119.2M
Net Invested Capital	1.0B	1.2B	1.4B	1.9B	2.2B	1.1B
Net Working Capital	657.9M	657.2M	687.7M	936.5M	1.1B	574.3M
Property Plant And Equipment Net	126.7M	192.9M	389.8M	490.9M	564.5M	285.2M
Property Plant And Equipment Gross	268.3M	334.7M	389.8M	490.9M	564.5M	377.2M

Currently Active Assets on Macroaxis

MSFT	Microsoft
V	Visa Class A
C	Citigroup
DD	Dupont De Nemours
GM	General Motors

Other Information on Investing in Xiamen Stock

Balance Sheet is a snapshot of the financial position of Xiamen Amoytop Biotech at a specified time, usually calculated after every quarter, six months, or one year. Xiamen Amoytop Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Xiamen Amoytop and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Xiamen currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Xiamen Reconciled Depreciation vs Ebitda Analysis

Reconciled Depreciation vs Ebitda

Reconciled Depreciation vs Ebitda Correlation Analysis

Correlation Coefficient

Reconciled Depreciation

Ebitda

Xiamen Amoytop fundamental ratios Correlations

Xiamen Amoytop Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Xiamen Amoytop fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Xiamen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Retained Earnings	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Stockholder Equity
Non Current Assets Total	+ 1.0	Retained Earnings
Total Current Assets	+ 1.0	Inventory

Short Long Term Debt	- 0.95	Net Tangible Assets
Short Long Term Debt	- 0.93	Inventory
Total Current Assets	- 0.92	Short Long Term Debt
Non Current Liabilities Other	- 0.91	Short Long Term Debt
Short Long Term Debt	- 0.91	Total Stockholder Equity
Common Stock Shares Outstanding	- 0.9	Short Long Term Debt